Congress extends tick-disease research funding through 2030
S. 2398 — Kay Hagan Tick Reauthorization Act · Filed by Susan Collins (R-ME) · 23 cosponsors · Introduced Jul 23, 2025 · Signed
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill reauthorizes two federal programs that fund research and public-health efforts on tick-borne diseases through 2030. It extends the National Strategy and Regional Centers of Excellence in Vector-Borne Diseases, and Enhanced Support to Health Departments programs, both of which were set to expire after 2025. The bill also makes technical corrections to how the Tick-Borne Disease Working Group is referenced in statute.
Why we flagged it
The bill's sole operative function is to extend the sunset dates of two existing federal public-health programs focused on vector-borne disease research and response. It is a routine reauthorization with technical corrections.
What the text implies
- Reauthorization through 2030 commits federal funding for five additional years; any future defunding or program restructuring would require affirmative legislative action rather than occurring by default expiration.
- Technical amendment changing 'in coordination with' to 'acting through' may subtly shift governance structure of the Tick-Borne Disease Working Group, though the practical effect depends on how existing statute defines those terms.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Ordinary citizens benefit from continued federal funding for tick-borne disease research, surveillance, and public-health response. Tick-borne illnesses (Lyme disease, Rocky Mountain spotted fever, etc.) pose direct health risks to the public; reauthorization ensures uninterrupted federal support for prevention, diagnosis, and treatment infrastructure.
Who stands to gain
- public health departments
- academic medical centers and research institutions
- CDC and NIH (federal agencies receiving appropriations)
Named in the bill
CDC, NIH, Public Health Service, Tick-Borne Disease Working Group, State and local health departments, Regional Centers of Excellence
Where it stands
23 cosponsors: 15 Democrats, 7 Republicans, 1 Independents.
- Jul 23, 2025 — Introduced · Congress.gov: “Introduced in Senate”
- Jul 23, 2025 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
- Jul 30, 2025 — Reported out of committee · Congress.gov: “Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature…”
- Aug 6, 2026 — Passed the Senate · Congress.gov: “Passed Senate with an amendment by Voice Vote. (consideration: CR S4494-4495; text: CR S4494-4495)”
- Sep 15, 2026 — Passed both chambers · Congress.gov: “On motion to suspend the rules and pass the bill Agreed to by voice vote”
- Sep 15, 2026 — Floor vote scheduled · Congress.gov: “Mr. Guthrie moved to suspend the rules and pass the bill”
- Sep 29, 2026 — Sent to president · Congress.gov: “Presented to President”
- Sep 30, 2026 — Signed into law · Congress.gov: “Became Public Law No: 119-118”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $30,000 in lobbying spend. A filing names 14 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Susan Collins, the sponsor, reported $2,459,513 in PAC receipts in the 2026 cycle.
- Entomological Society of America — $30,000 on 1 filing
Lobbying Disclosure Act filings through Jul 15, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (949 characters) on Jul 10, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 15, 2026 · page rendered 2026-10-20.
“Congress extends tick-disease research funding through 2030” QuorumCivic. https://share.quorumcivic.app/bill/119/s2398 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.